1. Home
  2. RCKT vs PBFS Comparison

RCKT vs PBFS Comparison

Compare RCKT & PBFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • PBFS
  • Stock Information
  • Founded
  • RCKT 1999
  • PBFS 1889
  • Country
  • RCKT United States
  • PBFS United States
  • Employees
  • RCKT N/A
  • PBFS N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • PBFS Banks
  • Sector
  • RCKT Health Care
  • PBFS Finance
  • Exchange
  • RCKT Nasdaq
  • PBFS Nasdaq
  • Market Cap
  • RCKT 328.6M
  • PBFS 311.6M
  • IPO Year
  • RCKT N/A
  • PBFS N/A
  • Fundamental
  • Price
  • RCKT $3.19
  • PBFS $13.50
  • Analyst Decision
  • RCKT Buy
  • PBFS
  • Analyst Count
  • RCKT 13
  • PBFS 0
  • Target Price
  • RCKT $12.96
  • PBFS N/A
  • AVG Volume (30 Days)
  • RCKT 5.7M
  • PBFS 20.2K
  • Earning Date
  • RCKT 11-06-2025
  • PBFS 11-11-2025
  • Dividend Yield
  • RCKT N/A
  • PBFS N/A
  • EPS Growth
  • RCKT N/A
  • PBFS 50.26
  • EPS
  • RCKT N/A
  • PBFS 0.91
  • Revenue
  • RCKT N/A
  • PBFS $91,369,000.00
  • Revenue This Year
  • RCKT N/A
  • PBFS N/A
  • Revenue Next Year
  • RCKT $108.43
  • PBFS N/A
  • P/E Ratio
  • RCKT N/A
  • PBFS $14.69
  • Revenue Growth
  • RCKT N/A
  • PBFS 23.15
  • 52 Week Low
  • RCKT $2.19
  • PBFS $10.60
  • 52 Week High
  • RCKT $22.01
  • PBFS $13.45
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 47.80
  • PBFS 66.16
  • Support Level
  • RCKT $3.09
  • PBFS $13.17
  • Resistance Level
  • RCKT $3.29
  • PBFS $13.44
  • Average True Range (ATR)
  • RCKT 0.16
  • PBFS 0.17
  • MACD
  • RCKT -0.02
  • PBFS 0.01
  • Stochastic Oscillator
  • RCKT 14.64
  • PBFS 100.00

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About PBFS Pioneer Bancorp Inc.

Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.

Share on Social Networks: